Venus Remedies Ltd announced this week that it has received marketing authorization from Saudi Arabia for Docetaxel, a commonly used chemotherapy drug. The announcement comes three months after the company received Saudi Food and Drug Authority...
Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults was approved by the US Food and Drug Administration on Wednesday, making it the second shot against the common respiratory disease that can be fatal for seniors...
DKMS Stiftung Leben Spenden awards four outstanding young scientists with the highly endowed DKMS John Hansen Research Grant: Ivan Cohen, PhD, from the University of Pennsylvania, Eiko Hayase, MD, PhD, from the University of Texas MD...
Lupin, Enzene Biosciences Announce Strategic Partnership to launch Cetuximab in India
AstraZeneca Pharma India has announced the appointment of Bhavana Agrawal as chief finance officer (CFO) with effect from October 1, 2023, following a transition period, according to a company statement issued today. She succeeds Rajesh Marwaha,...
US drugmaker Pfizer Inc said this week late-stage study data for its experimental hemophilia therapy showed superiority to the current standard of care treatment in reducing bleeding rates in patients...
Zomato, the food ordering and delivery platform, has partnered with Dial4242 to provide ambulance services and medical support to delivery partners via mobile medical units (MMUs). The MMU allows Zomato's delivery partners to get free health checks..
Sun Pharmaceutical Industries Limited (along with its subsidiaries and/or associated companies, "Sun Pharma") and Philogen S.p.A announced a licensing agreement for the commercialization of Philogen's specialty product, Nidlegy (Daromun), in Europe,.
Successful pharma leaders must have a deep understanding of the drug development process and a passion for innovation. They must also have strong communication skills and the ability to motivate their team to achieve their goals.
Lexicon Pharmaceuticals, Inc. announced that the FDA has approved Inpefa (sotagliflozin), a once-daily oral tablet, to reduce the risk of cardiovascular death, hospitalisation for heart failure, and urgent heart failure visit in adults with heart...
, CDSCO.jpg)
